Table of Content

• BEAULIEU APPOINTED CVM DEPUTY DIRECTOR [ARCHIVED]
  by Karen A. Kandra
• FDA PUBLISHES SUBSTANTIAL EVIDENCE FINAL RULE [ARCHIVED]
• FDA AND USDA-ARS PARTICIPATE IN PLANNING SURVEILLANCE PROGRAM FOR FOODBORNE PATHOGENS IN MEXICO [ARCHIVED]
  by Katherine Hollinger, D.V.M., M.P.H.
• FDA PROPOSES TO RECLASSIFY SHEEP AS A MINOR SPECIES [ARCHIVED]
• CVM SPONSORED RESEARCH AND ADVANCES IN TECHNOLOGY [ARCHIVED]
• FDA HOSTS A FOLLOW-UP WORKSHOP ON BSE FEED REGULATION [ARCHIVED]
  by Paul M. Raynes, Deputy Director, Division of Federal-State Relations, FDA Office of Regional Operations
• AQUACULTURE UPDATE [ARCHIVED]
• VETERINARY FEED DIRECTIVE [ARCHIVED]
  by Ron Scherzberg
• FDA SPONSORS WORKSHOP ON MICROBIOLOGICAL SAFETY OF DRUG RESIDUES IN FOOD [ARCHIVED]
• FEED METHODS WORKSHOP OFFERED [ARCHIVED]
• VICH DRAFT GUIDANCE DOCUMENTS AVAILABLE [ARCHIVED]
• FDA ISSUES FINAL GUIDANCE FOR RX DRUG ADVERTISEMENTS [ARCHIVED]
• COMPARATIVE PHARMACOKINETICS IN DIFFERENT PRODUCTION CLASSES OF CATTLE [ARCHIVED]
  by Ian F. De Veau, Ph.D.
• FINAL GUIDANCE PUBLISHED ON VALIDATION OF ANALYTICAL PROCEDURES [ARCHIVED]
• GOOD CLINICAL PRACTICES DRAFT GUIDANCE DOCUMENT AVAILABLE [ARCHIVED]
• BSE FEED REGULATION TEAM RECEIVES VICE PRESIDENTIAL AWARD [ARCHIVED]
• PLAIN LANGUAGE: THE CVM VFD REGULATION [ARCHIVED]
  by Joanne M. Kla
• FDA APPROVES FIRST TOPICAL DRUG FOR HEARTWORM PREVENTION IN DOGS AND CATS [ARCHIVED]
• CONSENT DECREE ENTERED IN ANIMAL DRUG CGMP CASE [ARCHIVED]
• REGULATORY ACTIVITIES - September/October 1999 [ARCHIVED]
• NEW ANIMAL DRUG APPROVALS - September/October 1999 [ARCHIVED]
• ABBREVIATED NEW ANIMAL DRUG APPROVALS - September/October 1999 [ARCHIVED]
• SUPPLEMENTAL NEW ANIMAL DRUG APPROVALS - September/October 1999 [ARCHIVED]